Fortnightly Review: Management of genital candidiasis

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ education articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

D W Denning

Correspondence to: Dr D W Denning, Department of Infectious Diseases and Tropical Medicine (Monsall Unit), North Manchester General Hospital, Manchester M8 5RB.

Abstract

Vaginal candidiasis affects about 75% of women, 40-50% having recurrent episodes
Pruritus vulvae and vaginal discharge are the cardinal symptoms
Candida albicans accounts for about 90% of infections and C glabrata for 5%
C glabrata infections are often resistant to azoles
Recurrent episodes require clinical examination, culture of swabs, and consideration of underlying disease
Male partners who do not have symptoms need not be examined, have swabs taken for culture, or be treated
Reduction of intestinal colonisation is of no value in preventing recurrence